New Valeant Pharmaceuticals Intl Inc Board Sends Message As Firm Reinstates EarningsMark Melin
The day after what was described as “the most brutal” Senate grilling of a corporate executives in memory, a beat-down involving Valeant Pharmaceuticals, the company restated earnings and materially re-shuffled the board of directors. While the restatement was material, it was the new board members focused on fraud and medical issues that points to the future. For investors, the question going forward is likely to have . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.